Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

OTHER 32 INDUSTRY 13 NETWORK 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiotherapy 10 Cisplatin 9 Carboplatin 7 Capecitabine 6 Neoadjuvant Therapy 5 Gemcitabine 5 Fluorouracil 5 Docetaxel 5 Paclitaxel 4 Cyclophosphamide 4 Trastuzumab 3 Tamoxifen 3 Surgical Procedures, Operative 3 Oxaliplatin 3 Hydralazine 3 Etoposide 3 Drug Therapy 3 pertuzumab 2 pegylated granulocyte colony-stimulating factor 2 palbociclib 2 endostar protein 2 Valproic Acid 2 Tranexamic Acid 2 Temozolomide 2 TP protocol 2 Saline Solution 2 Radiotherapy, Adjuvant 2 Radiation 2 Proton Pump Inhibitors 2 Pemetrexed 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER_GOV × Sodium Chloride × Clear all

NCT01836575 2013-04-22

PS2

Instituto Nacional de Cancer, Brazil

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡